From: First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality
Time point
Baseline
Month 2
Month 4
Month 6
Month 8
Month 10
Month 12
Proportion of expected NCF assessments completed (%)
99
91
78
68
67
52
59